Haemonetics | HAE - Aktuelle Verpflichtungen

Aktienkurs
59.93
Täglich Wechseln
0.31 0.52%
Monatlich
7.15%
Jährlich
-4.13%
Q2 Prognose
58.65




Aktuelle Verpflichtungen Veränderung Datum
Avanos Medical USD 165.2M 17.3M 2025-12
Baxter International USD 2.97B 805M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Cerus USD 88.43M 4.08M 2025-09
Cooper Companies USD 1.6B 482.9M 2025-12
Fresenius EUR 9.56B 1.27B 2025-09
Fresenius Medical Care EUR 6.25B 485.68M 2025-12
Globus Medical USD 498.5M 32.54M 2025-12
Haemonetics USD 539.87M 8.45M 2025-12
ICU Medical USD 498.86M 5.96M 2025-12
Intuitive Surgical USD 2.51B 3.2M 2026-03
Masimo USD 371.6M 1.9M 2025-12
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 239.76M 9.29M 2025-12
Neogen USD 150.6M 3.55M 2025-12
OraSure Technologies USD 39.8M 453K 2025-12
Plus Therapeutics USD 12.31M 1.3M 2025-12
Quidel USD 966.1M 198.2M 2025-12
ResMed USD 1.25B 7.39M 2025-12
STAAR Surgical USD 68.5M 6.87M 2025-12
Steris USD 922.3M 33.4M 2025-12
Stryker USD 7.79B 380M 2025-12
Surmodics USD 19.44M 1.1M 2025-06
Teleflex USD 762.03M 11.01M 2025-12
Terumo JPY 539.7B 243.4B 2025-12
Thermo Fisher Scientific USD 14.62B 568M 2026-03
US Physical Therapy USD 139.04M 23.96M 2025-12
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12